Chemoinformaics analysis of Oxidoselina-1,3,7(11)-trien-8-one
| Molecular Weight | 232.323 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 15 |
| Exact Molecular Weight | 232.146 | nRing | 3 |
| Solubility: LogS | -2.992 | nHRing | 1 |
| Solubility: LogP | 2.655 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.601 |
| Synth | 5.155 |
| Natural Product Likeliness | 2.459 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.497 |
| Pgp-sub | 0.003 |
| HIA | 0.014 |
| CACO-2 | -4.71 |
| MDCK | 0.0000334 |
| BBB | 0.981 |
| PPB | 0.743297 |
| VDSS | 1.808 |
| FU | 0.298071 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.654 |
| CYP2c19-inh | 0.177 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.209 |
| CYP2c9-sub | 0.07 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.186 |
| CYP3a4-inh | 0.603 |
| CYP3a4-sub | 0.877 |
| CL | 8.752 |
| T12 | 0.696 |
| hERG | 0.016 |
| Ames | 0.04 |
| ROA | 0.895 |
| SkinSen | 0.231 |
| Carcinogencity | 0.955 |
| EI | 0.038 |
| Respiratory | 0.972 |
| NR-Aromatase | 0.098 |
| Antiviral | Yes |
| Prediction | 0.85568 |